Skip Navigation


Rheumatology Advance Access originally published online on March 1, 2005
Rheumatology 2005 44(8):959-961; doi:10.1093/rheumatology/keh593
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow CME/CE:
Take the course for this article:
 Rheumatology Second Quarter 2005 Quiz
Right arrow All Versions of this Article:
44/8/959    most recent
keh593v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Simonini, G.
Right arrow Articles by Athreya, B. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simonini, G.
Right arrow Articles by Athreya, B. H.
Related Collections
Right arrow Kawasaki Disease
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

EDITORIAL

Diagnosing Kawasaki syndrome: the need for a new clinical tool

G. Simonini, C. D. Rosè1, A. Vierucci2, F. Falcini and B. H. Athreya1

Department of Paediatrics-Rheumatology Unit, University of Firenze, Italy, 1 Division of Rheumatology, Department of Pediatrics, A. I. duPont Hospital for Children, Wilmington, DE and Department of Pediatrics, Thomas Jefferson University, Philadelphia, PA, USA and 2 Department of Paediatrics, University of Firenze, Italy

Correspondence to: G. Simonini, Department of Paediatrics-Rheumatology Unit, Via Pico della Mirandola 24, 50132 Firenze, Italy. E-mail: gabriele.simonini@unifi.it

The first 150 words of the full text of this article appear below.

Kawasaki syndrome (KS) is the leading cause of acquired heart disease in children in several parts of the world. It is estimated that up to 3500 children in the US develop KS each year. In the absence of therapy, 15–25% will develop coronary artery abnormalities as a result of intense vasculitis [1, 2]. These include aneurysms and ectasia, responsible for the 2% mortality reported in Japanese children with KS before the introduction of intravenous immunoglobulin (IVIG). Smaller aneurysms tend to resolve over a period of 1–2 yr, but giant aneurysms predispose to risk for myocardial ischaemia and infarction requiring anticoagulation therapy and close follow-up. The timely administration of IVIG has been shown to reduce the incidence of coronary artery disease to about 3–8% [3] and mortality to less than 0.2% [4]. Rarely, children who subsequently develop coronary artery stenosis will require more aggressive . . . [Full Text of this Article]

Diagnosis of atypical/incomplete KS: the clinician's dilemma


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
J. F. Bastian and H. I. Kushner
Diagnosing Kawasaki syndrome
Rheumatology, February 1, 2006; 45(2): 240 - 241.
[Full Text] [PDF]